Learn more about these therapeutic areas
Choose one of the following therapeutic areas in which we are dedicated at Sanofi
Cardiovascular
Diabetes
Atopic Dermatitis
Asthma
Nasal Polyps
Rare Diseases
Vaccines
Multiple Sclerosis
Prurigo Nodularis
Science
We offer you a 360º view of relevant and trustworthy content in our therapeutic areas
About Type 2 Inflammation - Atopic Dermatitis
N-PASS Handbook
Influenza in Asthmatic Patients
About Type 2 Inflammation – Asthma
About Type 2 Inflammation - Nasal Polyps
Type 2 Inflammation in CRSwNP
Consider Dupixent for Asthmatic Patients with High EOS
Consider Dupixent For asthmatic patients with OCS use
The BRIGHT Study
Influenza in Diabetic Patients
The Lixilan-L Study
Basal insulin and beyond
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources
02:12
Atopic Dermatitis story
01:19
Prevalence of Asthma
02:01
Asthma Assessment Tools (EPOS)
02:12
Patient Case – Dupilumab in Atopic Dermatitis
03:15
Asthma Control Tests (ACT) Overview
N-PASS Handbook
Type 2 Inflammation in CRSwNP
Basal insulin and beyond
5:12
SoliMix Study Results Summary Video
ADA 2021: Solimix Trial Summary
Hospitalization Rates for Acute Diabetes Complications
What is time-in-range?
Events
What is Epilepsy
Insulin@100 Live Webinar. Discovery. Transformation. Legacy.
Roadmap to antimicrobial prescribing
Diabetes Guidelines in Ramadan
24:30
Dyslipidemia Webinars: Optimizing Dyslipidemia management
17:39
Introduction to Gaucher Disease by Prof. Moeenaldeen D. Alsayed
Nutrition and Insulin management in Ramadan
17:39
Soliqua and Unmet Needs Webinar Summary
Type 2 Diabetes Cost Effective Management
17:39
Do not Keep it masked! Prof. Fatih Ezgü
Dyslipidemia Webisodes: Mortality data with Prof. Tunon
Pertussis & Polio-based Vaccines; Throughout LIFE Webinar Session
Sanofi in News
Discover headline news on how Sanofi is engaged with the medical community
Sanofi signs multi-pronged partnership with Dasman Diabetes Institute to intensify diabetes prevention in Kuwait
